Industry News, Press, Studies, Tru-D News, Tru-D Technology, Uncategorized, Videos

UNC-TV Releases New Video Featuring Tru-D and the BETR-D Study

The University of North Carolina’s “UNC-TV” has released a new video on the Benefits of Enhanced Terminal Room-Disinfection (BETR-D) study, the first and only randomized clinical trial on UV disinfection. The study proved that Tru-D could cut transmission of four major superbugs by a cumulative 30% among patients who entered the

Read More
Posted 05.18.17
  • Share

Hospital News, Industry News, Press, Tru-D News, Tru-D Technology, Uncategorized

From Duke Health: UVC Light Helps Hospitals Fight Drug-Resistant Superbugs

From Clinical Practice Today by Duke Health:

Read More
Posted 05.10.17
  • Share

Industry News, Studies, Tru-D News, Tru-D Technology, Uncategorized

BETR-D Study Shows 11% C. diff Reduction

Shield Design with 11% Hospital C. Diff Reduction

The Benefits of Enhanced Terminal Room-Disinfection (BETR-D) study is the first and only randomized clinical trial on UV disinfection. The study’s primary outcome showed that enhanced terminal room disinfection strategies that utilized Tru-D reduced the risk of acquisition and infection by a cumulative 30 percent among patients who entered the

Read More
Posted 04.26.17
  • Share

Hospital News, Industry News, Tru-D News, Tru-D Technology, Uncategorized

Q&A With Chesapeake Regional Healthcare

Chesapeake Regional Healthcare was one of the nine hospitals that participated in the CDC-funded, $2M Benefits of Enhanced Terminal Room-Disinfection (BETR-D) randomized clinical trial on UV disinfection. The study was conducted from 2012-2014 throughout the Duke Infection Control Outreach Network, and, during that time, CRH saw a 12 percent reduction in its

Read More
Posted 04.19.17
  • Share

Hospital News, Industry News, Press Releases, Studies, Tru-D News, Tru-D Technology, Uncategorized

Tru-D SmartUVC Helps Reduce C. diff Infections at Chesapeake Regional

With the help of a fleet of germ-eliminating UV robots, Chesapeake Regional Healthcare (CRH) experienced a marked decrease in its Clostridium difficile (C. diff) infection rates. After participating in a study on UV disinfection and seeing significant results, CRH has invested in Tru-D SmartUVC to help with its infection rates.

Read More
Posted 04.07.17
  • Share

Never miss the latest in UV news.
Subscribe to UVC360 today.

Sign Up »